Lataa...
Ligandomics: a paradigm shift in biological drug discovery
As productivity of pharmaceutical research and development (R&D) for small-molecule drugs declines, the trend in drug discovery strategies is shifting towards biologics, which predominantly target secreted or cell surface proteins. Receptors and ligands are the most-valuable drug targets. In con...
Tallennettuna:
| Julkaisussa: | Drug Discov Today |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5849512/ https://ncbi.nlm.nih.gov/pubmed/29326083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2018.01.013 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|